News
River BioMedics secures €1.8 mln seed investment to Progress its Cardiovascular Disease Programs
Venture Challenge alumnus River BioMedics, a drug discovery company using advanced 3D human cardiac models, today announced the closure of a 1.8 million Euro seed funding round to progress its pipeline of cardiovascular disease targets and compounds
NutriLeads’ clinical trial demonstrates that daily intake of BeniCaros helps support protective innate immune responses
Pivotal study published in Nutrients showing that Nutrileads’ proprietary carrot-derived rhamnogalacturonan-I (cRG-I) (commercially known as BeniCaros) fiber, accelerates protective anti-viral immune responses and reduces symptoms after an exper
Incircular awarded €2.5 mln EIC Transition Grant
Venture Challenge alumnus Incircular was one of the 42 projects that received a EIC transition grant in the first ever round of this new scheme to support projects to take breakthrough technologies from the lab into the real world.
Predica Diagnostics and TenWise announce collaboration on development of MicroBioDx, a novel microbiome-host profiling tool for health and disease
Leiden/Nijmegen - TenWise BV and Venture Challenge alumnus Predica Diagnostics BV have received financial support from the Dutch RVO (
Venture Challenge Winner Ambagon Therapeutics Raises $85mln Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline
San Fransisco / Eindhoven – Ambagon Therapeutics, a biotechnology company unlocking intrinsically disordered proteins and other difficult-to-target protein classes, today announced an $85 million Series A to augment its
SeraNovo and Graviton deepen collaboration and enter into a second license agreement to develop formulations for Graviton's ROCK-2 inhibitors
Venture Challenge Winner SeraNovo is pleased to announce the closing of a second license agreement with Graviton Bioscience Corporation (Graviton), a biopharmaceutical company engaged in the research and development of small molecules in the fields of oncol
NTRC announces IND approval for the TTK/PLK dual inhibitor BAL0891 in its collaboration with Swiss pharmaceutical company Basilea
Oss – Venture Challenge alumnus NTRC, specialized in discovery and development of innovative kinase inhibitors to treat cancer patients, today announces that the U.S.
ATRO Medical closes a new financing round for the Trammpolin® meniscus prosthesis
Nijmegen - Venture Challenge Alumnus ATRO Medical announces the successful closure of a €1,9 million financing round.
Venture Challenge alumnus Sirius Medical announces second closing of A-round financing to accelerate US expansion
Eindhoven, Netherlands – Sirius Medical, a leader in tumor navigation technology, announced today the closing of its second round of series A financing.
Venture Challenge Spring 2022 open for applications!
Curious what the Venture Challenge may bring you? This is what last year's alumni say about it.